Literature DB >> 32145280

Effects of High-Intensity Interval Training After Stroke (the HIIT-Stroke Study): A Multicenter Randomized Controlled Trial.

Tor Ivar Gjellesvik1, Frank Becker2, Arnt Erik Tjønna3, Bent Indredavik4, Halvard Nilsen5, Berit Brurok6, Tom Tørhaug7, Maja Busuladzic8, Stian Lydersen9, Torunn Askim4.   

Abstract

OBJECTIVE: To examine if 8 weeks of high-intensity interval training (HIIT) in addition to standard care would increase and maintain peak oxygen uptake (Vo2peak) more than standard care alone in patients with stroke.
DESIGN: This was a single-blind, multicenter, parallel group, randomized controlled trial.
SETTING: Specialized rehabilitation units at 3 Norwegian hospitals. PARTICIPANTS: Participants (N=70), 3 months to 5 years after first-ever stroke, were randomly assigned to the intervention group (n=36) or the control group (n=34); 42% were women, mean age was 57.6±9.3 years, mean time post stroke was 26.4±14.5 months. INTERVENTION: The intervention was 8 weeks: 3 times a week with HIIT treadmill training with work periods of 4 × 4 minutes at 85%-95% of peak heart rate interspersed with 3 minutes of active recovery at 50%-70% of peak heart rate. The control group received standard care according to national guidelines. OUTCOMES: The primary outcome, analyzed by intention-to-treat, was Vo2peak measured as liters per minute 12 months after inclusion. Secondary outcome measures were blood pressure and blood profile.
RESULTS: Mean baseline Vo2peak was 2.63±1.08 L·min-1 vs 2.87±0.71 L·min-1, while at 12 months Vo2peak was 2.70±1.00 L·min-1 vs 2.67±0.76 L·min-1 (P=.068) in the intervention and control groups, respectively. There was a significant and greater improvement in the intervention group compared with the control group at 12 months in 3 of 6 secondary outcomes from the peak test but no significant differences for blood pressure or blood profile.
CONCLUSIONS: The HIIT intervention, which was well-tolerated in this sample of well-functioning survivors of stroke, was not superior to standard care in improving and maintaining Vo2peak at the 12-month follow-up. However, secondary results from the peak test showed a significant improvement from before to immediately after the intervention.
Copyright © 2020 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrovascular disorders; Exercise; Rehabilitation; Stroke

Year:  2020        PMID: 32145280     DOI: 10.1016/j.apmr.2020.02.006

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor.

Authors:  Andrew Keech; Kimberley Way; Katie Holgate; Jennifer Fildes; Praveen Indraratna; Jennifer Yu
Journal:  Int J Cardiol       Date:  2020-08-31       Impact factor: 4.164

2.  Associations Between Time After Stroke and Exercise Training Outcomes: A Meta-Regression Analysis.

Authors:  Susan Marzolini; Che-Yuan Wu; Rowaida Hussein; Lisa Y Xiong; Suban Kangatharan; Ardit Peni; Christopher R Cooper; Kylie S K Lau; Ghislaine Nzodjou Makhdoom; Maureen Pakosh; Stephanie A Zaban; Michelle M Nguyen; Mohammad Amin Banihashemi; Walter Swardfager
Journal:  J Am Heart Assoc       Date:  2021-12-16       Impact factor: 6.106

Review 3.  What Is Intensity and How Can It Benefit Exercise Intervention in People With Stroke? A Rapid Review.

Authors:  Gavin Church; Christine Smith; Ali Ali; Karen Sage
Journal:  Front Rehabil Sci       Date:  2021-09-21

4.  An Intelligent Cardiopulmonary Training System and Adherence to Training Intensity: A Feasibility Study.

Authors:  Li Wei; Ju-Yang Chi; Jane C-J Chao; Yen-Nung Lin
Journal:  Int J Environ Res Public Health       Date:  2022-07-07       Impact factor: 4.614

5.  Effects of high intensity interval exercise on cerebrovascular function: A systematic review.

Authors:  Alicen A Whitaker; Mohammed Alwatban; Andrea Freemyer; Jaime Perales-Puchalt; Sandra A Billinger
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.